
Georgia Lawmakers Face Push to Expand Medical Cannabis Beyond Low-THC
State's restrictive program allows only low-THC oil as advocates and patients demand broader access
Georgia legislators are heading into 2026 facing mounting pressure to expand the state's medical cannabis program beyond its current restriction to low-THC oil products.
The push comes from patient advocates, medical professionals, and industry stakeholders who argue the state's limited framework—one of the most restrictive in the nation—fails to serve patients who could benefit from higher-THC formulations and alternative delivery methods.
Georgia's medical cannabis law, enacted in 2015 and expanded in 2019, allows registered patients with specific qualifying conditions to possess up to 20 ounces of low-THC oil containing no more than 5% THC. But the program prohibits smoking, vaping, and higher-THC products that are standard in most other medical states.
The Numbers
The state issued production licenses to six companies in 2021, but dispensaries only began opening in 2023 after years of regulatory delays. Currently, Georgia has approximately 30,000 registered medical cannabis patients—a fraction of what advocates say the number would be with a more comprehensive program.
By comparison, neighboring Florida serves over 800,000 medical cannabis patients with a program that includes smokable flower and higher-THC products. Arkansas, with roughly half Georgia's population, has more than 80,000 registered patients.
Industry Response
Licensed producers in Georgia are watching closely. The state's six vertical operators invested millions in cultivation and processing facilities, but the limited product offerings and patient count have constrained revenue potential.
"The current framework was a starting point, but it's clear that patients need more options," said one industry source familiar with the legislative discussions who spoke on condition of anonymity. "Other states have shown that comprehensive medical programs can operate safely and effectively."
Advocacy groups are preparing to lobby the legislature when it convenes in January. Their proposals include adding smokable flower, expanding the list of qualifying conditions, and raising THC limits for certain medical formulations.
Political Landscape
Georgia's conservative legislature has historically moved cautiously on cannabis policy. The state decriminalized possession of low-THC oil for medical patients but stopped short of creating a cultivation framework until 2019, and even then implementation dragged on for years.
However, public opinion has shifted. Recent polling shows that over 80% of Georgians support medical cannabis access, and more than half support full adult-use legalization. That's created political space for expansion advocates to make their case.
Several key legislators have indicated openness to revisiting the program's restrictions, though no formal bills have been filed yet. The 2026 session could prove pivotal—it's the first legislative opportunity since dispensaries began operating at scale.
What's Next
Legislative watchers expect multiple cannabis-related bills to be introduced when the General Assembly convenes. Beyond medical expansion, some lawmakers may push for broader reforms including adult-use legalization, though that faces steeper political hurdles.
The medical expansion effort will likely focus on incremental changes: adding smokable flower first, then potentially addressing THC limits and qualifying conditions. Advocates say a measured approach has the best chance of success in Georgia's political environment.
Timing matters. With dispensaries now operational and a growing patient base, lawmakers have real-world data from Georgia's own program to evaluate—not just examples from other states. That could make the difference in 2026.
This article is based on original reporting by mjbizdaily.com.
Original Source
This article is based on reporting from MJBizDaily.
Read the original articleOriginal title: "Georgia under pressure to expand low-THC medical cannabis in 2026"
Related Topics
Related Stories
LegislationConnecticut Expands Psychedelics Pilot as FDA Decision Looms
Connecticut's Joint Committee on Public Health advanced legislation expanding the state's psychedelic therapy pilot program to include first responders, as lawmakers prepare for potential FDA approval of MDMA and psilocybin treatments.
LegislationRescheduling Won't Fix Cannabis Industry Without Insurance Access
Cannabis industry experts argue Trump's rescheduling order won't stabilize the market without insurance reimbursement access, which matters more than tax relief for long-term viability.
LegislationVirginia Moves Closer to Legal Cannabis Sales as Bills Advance
Virginia's House and Senate advanced companion bills to legalize cannabis sales, moving the legislation closer to Governor Youngkin's desk despite his previous opposition.
More from Alex Morgan
View all articles
Bob Weir's Nuanced Cannabis Stance Defied 'Drug Band' Stereotypes

Rescheduling Won't Fix Cannabis Industry Without Insurance Access

Chicago's Cannabis Run Club Grows From 'Highdea' to Weekly Tradition

